United States · Series B startup

Who invested in Mercy BioAnalytics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$59Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $59MSept 2025
Investors
2
See who backed them

The rounds

  1. Sept 2025
    Series B$59M

    Source recorded

Everyone who backed them

PortfoliaVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Mercy BioAnalytics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Avestria VenturesVC firmPer its own site

Quick answers about Mercy BioAnalytics

Who invested in Mercy BioAnalytics?

Mercy BioAnalytics's investors include Hatteras Venture Partners and Portfolia.

How much has Mercy BioAnalytics raised?

Mercy BioAnalytics has raised $59M across 1 round since 2025.

When did Mercy BioAnalytics last raise?

Mercy BioAnalytics's most recent round was a Series B of $59M in Sept 2025.

What was Mercy BioAnalytics's biggest round?

Its most recent round, $59M in Sept 2025, is also its largest on record.

Who backed Mercy BioAnalytics first?

Mercy BioAnalytics's first round on record, in Sept 2025, was backed by Hatteras Venture Partners and Portfolia.

What stage is Mercy BioAnalytics at?

Mercy BioAnalytics's latest named round is a Series B, in Sept 2025.

Where is Mercy BioAnalytics based?

Mercy BioAnalytics is based in the United States.

Companies like Mercy BioAnalytics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.